A UT Health San Antonio lung specialist is the first in Texas to use a new genomic test to better and less invasively diagnose a patient with idiopathic pulmonary fibrosis (IPF), a serious, chronic, progressive and scarring lung disease with an average survival time of less than five years after diagnosis.
A Longer, Brighter Road Ahead for Patients at the Cystic Fibrosis Center at University Health System
A new generation of cystic fibrosis (CF) survivors are living longer and better thanks to improved treatments and understanding of the disease. The Cystic Fibrosis Center at University Health System’s Robert B. Green Campus offers a comprehensive, evidence-based approach to care from diagnosis through adulthood.
Neonatologist Adel Bougatef, MD, PhD, has partnered with San Antonio pediatric respiratory durable medical equipment provider Wave Healthcare to create an approach to mechanical ventilation that accounts for each individual patient’s unique lung compliance with the goal of reducing ventilation-related complications.
Baptist Health System Creates the South Texas Lung Institute, the Region’s First Dedicated Lung Disease Treatment Program
Lung cancer is responsible for more cancer-related deaths in both men and women in the United States than the next three most common cancers combined (colon, breast and pancreatic). According to the American Cancer Society, almost 220,000 people are diagnosed with lung cancer each year, with tobacco use being a major risk factor in the development of this cancer. However, early detection through screenings and treatment can decrease mortality rates and save lives.